These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 21150636)

  • 1. Chronic kidney disease elicits excessive increase in left ventricular mass growth in patients at increased risk for cardiovascular events.
    Cioffi G; Tarantini L; Frizzi R; Stefenelli C; Russo TE; Selmi A; Toller C; Furlanello F; de Simone G
    J Hypertens; 2011 Mar; 29(3):565-73. PubMed ID: 21150636
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Left ventricular hypertrophy among hypertensive patients with diminished glomerular filtration rate].
    Grabysa R; Cholewa M
    Pol Merkur Lekarski; 2008 Oct; 25(148):309-14. PubMed ID: 19145927
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The ratio of observed to predicted left ventricular mass is independently associated with increased cardiovascular events in patients with chronic kidney disease.
    Chen SC; Chang JM; Liu WC; Chen YY; Chen LI; Huang JC; Yang TK; Su HM; Chen HC
    Hypertens Res; 2012 Aug; 35(8):832-8. PubMed ID: 22456347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Left ventricular hypertrophy versus chronic kidney disease as predictors of cardiovascular events in hypertension: a Greek 6-year-follow-up study.
    Tsioufis C; Vezali E; Tsiachris D; Dimitriadis K; Taxiarchou E; Chatzis D; Thomopoulos C; Syrseloudis D; Stefanadi E; Mihas C; Katsi V; Papademetriou V; Stefanadis C
    J Hypertens; 2009 Apr; 27(4):744-52. PubMed ID: 19516174
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impaired global myocardial flow dynamics despite normal left ventricular function and regional perfusion in chronic kidney disease: a quantitative analysis of clinical 82Rb PET/CT studies.
    Fukushima K; Javadi MS; Higuchi T; Bravo PE; Chien D; Lautamäki R; Merrill J; Nekolla SG; Bengel FM
    J Nucl Med; 2012 Jun; 53(6):887-93. PubMed ID: 22562499
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence and factors related to inappropriately high left ventricular mass in patients with rheumatoid arthritis without overt cardiac disease.
    Cioffi G; Viapiana O; Ognibeni F; Dalbeni A; Giollo A; Adami S; Gatti D; Russo G; Barbati G; Cherubini A; Di Lenarda A; Rossini M
    J Hypertens; 2015 Oct; 33(10):2141-9. PubMed ID: 26237559
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Left ventricular hypertrophy and geometry in hypertensive patients with chronic kidney disease.
    Nardi E; Palermo A; Mulè G; Cusimano P; Cottone S; Cerasola G
    J Hypertens; 2009 Mar; 27(3):633-41. PubMed ID: 19262231
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Electrocardiographic characteristics and metabolic risk factors associated with inappropriately high left ventricular mass in patients with electrocardiographic left ventricular hypertrophy: the LIFE Study.
    Palmieri V; Okin PM; de Simone G; Bella JN; Wachtell K; Gerdts E; Boman K; Nieminen MS; Dahlöf B; Devereux RB
    J Hypertens; 2007 May; 25(5):1079-85. PubMed ID: 17414673
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inappropriately high left ventricular mass in patients with type 2 diabetes mellitus and no overt cardiac disease. The DYDA study.
    Cioffi G; Faggiano P; Lucci D; Di Lenarda A; Mureddu GF; Tarantini L; Verdecchia P; Comaschi M; Giorda CB; Velussi M; Chinali M; Latini R; Masson S; De Simone G;
    J Hypertens; 2011 Oct; 29(10):1994-2003. PubMed ID: 21881524
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sex differences in hypertension-related renal and cardiovascular diseases in Italy: the I-DEMAND study.
    Muiesan ML; Ambrosioni E; Costa FV; Leonetti G; Pessina AC; Salvetti M; Trimarco B; Volpe M; Pontremoli R; Deferrari G; Rosei EA
    J Hypertens; 2012 Dec; 30(12):2378-86. PubMed ID: 23137952
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Moderate chronic kidney disease and left ventricular hypertrophy after aortic valve replacement for aortic valve stenosis.
    Benedetto U; Melina G; Angeloni E; Refice S; Scafani G; Roscitano A; Tonelli E; Sinatra R
    J Thorac Cardiovasc Surg; 2010 Apr; 139(4):881-6. PubMed ID: 20304136
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence of left ventricular hypertrophy in children with kidney disease: impact of method of indexation of left ventricular mass.
    Simpson JM; Savis A; Rawlins D; Qureshi S; Sinha MD
    Eur J Echocardiogr; 2010 Apr; 11(3):271-7. PubMed ID: 20015849
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inappropriately high left-ventricular mass in asymptomatic mild-moderate aortic stenosis.
    Cioffi G; de Simone G; Cramariuc D; Mureddu GF; Gerdts E
    J Hypertens; 2012 Feb; 30(2):421-8. PubMed ID: 22179090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic kidney disease and cardiovascular risk in hypertensive type 2 diabetics: a primary care perspective.
    Ravera M; Noberasco G; Re M; Filippi A; Gallina AM; Weiss U; Cannavò R; Ravera G; Cricelli C; Deferrari G
    Nephrol Dial Transplant; 2009 May; 24(5):1528-33. PubMed ID: 19073656
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of uric acid and left ventricular mass index with renal outcomes in chronic kidney disease.
    Chen SC; Chang JM; Yeh SM; Su HM; Chen HC
    Am J Hypertens; 2013 Feb; 26(2):243-9. PubMed ID: 23382409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kidney function and cardiovascular disease in the hypertensive population: the ERIC-HTA study.
    Redón J; Cea-Calvo L; Lozano JV; Fernández-Pérez C; Navarro J; Bonet A; González-Esteban J;
    J Hypertens; 2006 Apr; 24(4):663-9. PubMed ID: 16531794
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum adiponectin and cardiovascular risk in chronic kidney disease and kidney transplantation.
    Chitalia N; Raja RB; Bhandara T; Agrawal P; Kaski JC; Jha V; Banerjee D
    J Nephrol; 2010; 23(1):77-84. PubMed ID: 20091490
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Left ventricular hypertrophy in predialysis chronic kidney disease: impact of cardiomuscular stress markers].
    Kimura T; Iio K; Obi Y; Hayashi T
    Nihon Jinzo Gakkai Shi; 2007; 49(8):1007-13. PubMed ID: 18186229
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic kidney disease, cardiovascular risk, and response to angiotensin-converting enzyme inhibition after myocardial infarction: the Survival And Ventricular Enlargement (SAVE) study.
    Tokmakova MP; Skali H; Kenchaiah S; Braunwald E; Rouleau JL; Packer M; Chertow GM; Moyé LA; Pfeffer MA; Solomon SD
    Circulation; 2004 Dec; 110(24):3667-73. PubMed ID: 15569840
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inappropriate Left Ventricular Mass and Cardiovascular Disease Events and Mortality in Blacks: The Jackson Heart Study.
    Anstey DE; Tanner RM; Booth JN; Bress AP; Diaz KM; Sims M; Ogedegbe G; Muntner P; Abdalla M
    J Am Heart Assoc; 2019 Aug; 8(16):e011897. PubMed ID: 31407619
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.